Clinical Trials Directory

Trials / Completed

CompletedNCT07185581

Impulse Oscillometry in COPD Exacerbation

Evaluation of Small Airway Function During COPD Exacerbation and Recovery Using Impulse Oscillometry (IOS) Device

Status
Completed
Phase
Study type
Observational
Enrollment
41 (actual)
Sponsor
Deniz Bilici · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study aimed to evaluate small airway function during ECOPD and recovery periods using IOS. In this prospective single-center study, patients with ECOPD underwent evaluation of their pulmonary functions using IOS and spirometry during exacerbation and recovery (6-12 weeks after exacerbation). The patients were divided into two groups: mild exacerbations and (moderate and severe) exacerbations based on ROME criteria.A total of 41 patients were initially enrolled, with 38 completing the study. This study reveals that IOS can be easily used in ECOPD, and IOS parameters that reflect small airways (R5-R20, AX, and Fres) are correlated with FEV1% and the severity of dyspnea. Additionally, IOS parameters significantly improve during recovery, except for R20. Further research is necessary on its application in the functional assessment of patients with COPD exacerbations.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTImpulse OscillometryImpulse Oscillometry (IOS) is a simple, non-invasive, effort-independent method that uses sound waves to detect airway changes quickly. It only requires the patient to breathe normally to assess lung function by measuring both resistance and reactance of the airways. 6,7 These features of IOS suggest it may be a useful test for assessing patient respiratory function during exacerbation periods when airway resistance, airflow limitation, and respiratory muscle weakness further impair breathing.

Timeline

Start date
2024-03-01
Primary completion
2024-09-30
Completion
2024-09-30
First posted
2025-09-22
Last updated
2025-09-22

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07185581. Inclusion in this directory is not an endorsement.